BioSpace News Archive

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 18th Annual Global Healthcare Conference

Eli Lilly and Company (NYSE:LLY) will participate in the Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 17, 2020. Joshua Smiley, senior vice president and Lilly’s chief financial officer, will participate in a virtual fireside chat at 8:40 a.m., Eastern Time.

Poster Presentation Shares New Data on the Symptoms and Impacts of Fatigue Using a New Disease-Specific Scale Global Patient Survey Reveals Approximately Two-Thirds of Multiple Sclerosis Patients Experience Fatigue on a Daily Basis

Targazyme Inc., a late clinical-stage biopharmaceutical company developing novel fucosyltransferase enzyme technologies and products to improve clinical efficacy, safety, and cost of care outcomes for immuno-oncology and stem cell transplantation, announced today that it has recruited cancer immunotherapy industry veteran Jam

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (“Regulus”), today announced that Jay Hagan , President and Chief Executive Officer of Regulus, will present at the H.C. Wainwright 22 nd Annual Global Investment Conf

Veracyte, Inc . (Nasdaq: VCYT) announced today the initiation of a European study that will utilize the Delphi methodology to generate consensus regarding the clinical utility of genomic tests in breast cancer treatment. Led by an independent scientific committee of breast cancer

Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), today announced its management will present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on September 14-16, 2020. Robert Cobuzzi, Ph.D., chief executive officer, will present a corporate overview of the Company on Tuesday, September 15th

The Foundation recognizes industry partners who helped fund critical programs for patients and caregivers during uncertain times.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the publication of positive results from a study of antiviral activity of FDA approved drugs in a peer-reviewed article in the Journal of Virology.

Tetra Bio-Pharma Inc., a leader in cannabinoid-derived drug discovery and development, is pleased to announce the appointment of Jean-Francois Boily, CPA, CA, as Chief Financial Officer and member of the Company’s executive team.